ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 127 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,622 | -32.7% | 27,974 | +1.8% | 0.00% | – |
| Q2 2023 | $284,833 | +41.3% | 27,467 | +10.2% | 0.00% | – |
| Q1 2023 | $201,651 | -48.6% | 24,926 | 0.0% | 0.00% | – |
| Q4 2022 | $392,585 | +6.6% | 24,926 | +6.6% | 0.00% | – |
| Q3 2022 | $368,111 | +10.6% | 23,387 | -1.9% | 0.00% | – |
| Q2 2022 | $332,737 | -8.9% | 23,835 | +12.5% | 0.00% | – |
| Q1 2022 | $365,402 | -5.1% | 21,195 | -20.0% | 0.00% | – |
| Q4 2021 | $385,000 | -19.5% | 26,495 | -0.3% | 0.00% | – |
| Q3 2021 | $478,000 | +10.1% | 26,579 | +7.5% | 0.00% | – |
| Q2 2021 | $434,000 | +183.7% | 24,715 | -3.5% | 0.00% | – |
| Q1 2019 | $153,000 | +54.5% | 25,617 | +92.2% | 0.00% | – |
| Q4 2018 | $99,000 | -35.7% | 13,329 | +25.3% | 0.00% | – |
| Q3 2018 | $154,000 | -63.3% | 10,634 | -49.4% | 0.00% | – |
| Q2 2018 | $420,000 | +32.5% | 21,001 | +15.8% | 0.00% | – |
| Q1 2018 | $317,000 | -29.9% | 18,135 | -1.1% | 0.00% | – |
| Q4 2017 | $452,000 | -0.7% | 18,333 | +4.1% | 0.00% | -100.0% |
| Q3 2017 | $455,000 | +6.1% | 17,608 | +11.2% | 0.00% | 0.0% |
| Q2 2017 | $429,000 | +54.3% | 15,831 | +69.7% | 0.00% | – |
| Q1 2017 | $278,000 | +31.8% | 9,329 | +20.2% | 0.00% | – |
| Q4 2016 | $211,000 | +9.9% | 7,762 | +3.2% | 0.00% | – |
| Q3 2016 | $192,000 | +38.1% | 7,520 | 0.0% | 0.00% | – |
| Q2 2016 | $139,000 | +117.2% | 7,520 | +83.0% | 0.00% | – |
| Q1 2016 | $64,000 | – | 4,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |